Migdal Insurance & Financial Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $128M | Buy |
164,725
+74,090
| +82% | +$57.8M | 1.52% | 19 |
|
2025
Q1 | $74.9M | Buy |
90,635
+29,907
| +49% | +$24.7M | 1.05% | 28 |
|
2024
Q4 | $46.9M | Buy |
60,728
+24,390
| +67% | +$18.8M | 0.67% | 39 |
|
2024
Q3 | $32.2M | Sell |
36,338
-439
| -1% | -$389K | 0.52% | 44 |
|
2024
Q2 | $33.3M | Buy |
36,777
+34,893
| +1,852% | +$31.6M | 0.56% | 46 |
|
2024
Q1 | $1.47M | Sell |
1,884
-2,934
| -61% | -$2.28M | 0.02% | 130 |
|
2023
Q4 | $2.8M | Buy |
4,818
+1,567
| +48% | +$911K | 0.06% | 102 |
|
2023
Q3 | $1.76M | Buy |
+3,251
| New | +$1.76M | 0.04% | 122 |
|
2021
Q1 | – | Sell |
-153
| Closed | -$26K | – | 697 |
|
2020
Q4 | $26K | Sell |
153
-4
| -3% | -$680 | ﹤0.01% | 581 |
|
2020
Q3 | $23K | Buy |
+157
| New | +$23K | ﹤0.01% | 608 |
|
2018
Q4 | – | Sell |
-6,818
| Closed | -$732K | – | 769 |
|
2018
Q3 | $732K | Buy |
6,818
+4,035
| +145% | +$433K | 0.02% | 318 |
|
2018
Q2 | $237K | Buy |
2,783
+2,695
| +3,063% | +$230K | 0.01% | 418 |
|
2018
Q1 | $7K | Buy |
+88
| New | +$7K | ﹤0.01% | 562 |
|